Compare Stocks

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AOR iShares Core Growth Allocation ETF	$53.48 -0.1%	$54.63	$47.56 ▼ $55.74	$1.97B	0.62	263,840 shs	221,998 shs
ETX Eaton Vance Municipal Income 2028 Term Trust	$17.91 -0.3%	$17.98	$16.36 ▼ $18.60	N/A	N/A	30,884 shs	18,167 shs
HEB Hemispherx BioPharma	$0.48	$0.00	$1.69 ▼ $14.81	$1.17M	N/A	102,599 shs	176,741 shs

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AOR iShares Core Growth Allocation ETF	-0.11%	-2.34%	-2.82%	+1.33%	+6.66%
ETX Eaton Vance Municipal Income 2028 Term Trust	-0.17%	+0.73%	-2.77%	+0.56%	-2.93%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AOR iShares Core Growth Allocation ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HEB Hemispherx BioPharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AOR iShares Core Growth Allocation ETF	0.00	N/A	N/A	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	N/A	N/A	N/A	N/A
HEB Hemispherx BioPharma	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AOR iShares Core Growth Allocation ETF	N/A	N/A	N/A	N/A	N/A	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	$5.32M	N/A	N/A	N/A	N/A	N/A
HEB Hemispherx BioPharma	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AOR iShares Core Growth Allocation ETF	N/A	N/A	17.21	∞	N/A	N/A	N/A	N/A	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
HEB Hemispherx BioPharma	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AOR iShares Core Growth Allocation ETF	$1.08	2.02%	N/A	N/A	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	$0.78	4.36%	N/A	N/A	N/A
HEB Hemispherx BioPharma	N/A	N/A	N/A	N/A	N/A

Latest HEB, AOR, and ETX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/1/2024	ETX Eaton Vance Municipal Income 2028 Term Trust	Monthly	$0.0780	5.28%	4/22/2024	4/23/2024	4/30/2024
3/1/2024	ETX Eaton Vance Municipal Income 2028 Term Trust	monthly	$0.0782	5.2%	3/20/2024	3/21/2024	3/28/2024
2/1/2024	ETX Eaton Vance Municipal Income 2028 Term Trust	monthly	$0.0782	5.3%	2/21/2024	2/22/2024	2/29/2024

(Data available from 1/1/2013 forward)

Ownership

Institutional Ownership

Company	Institutional Ownership
AOR iShares Core Growth Allocation ETF	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	N/A
HEB Hemispherx BioPharma	N/A

Insider Ownership

Company	Insider Ownership
AOR iShares Core Growth Allocation ETF	N/A
ETX Eaton Vance Municipal Income 2028 Term Trust	N/A
HEB Hemispherx BioPharma	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AOR iShares Core Growth Allocation ETF	N/A	36.80 million	N/A	Not Optionable
ETX Eaton Vance Municipal Income 2028 Term Trust	N/A	N/A	N/A	Not Optionable
HEB Hemispherx BioPharma	31	2.44 million	N/A	Not Optionable

HEB, AOR, and ETX Headlines

Source	Headline
	Hemispherx BioPharma (NYSEAMERICAN:HEB) Shares Cross Above 200 Day Moving Average of $0.00 americanbankingnews.com - April 17 at 2:58 AM
	H-E-B to donate sauces to every Meals on Wheels of Odessa client oaoa.com - January 17 at 7:53 PM
	H-E-B hosting hiring fairs cbsnews.com - January 7 at 7:06 PM
	H-E-B bets on loyal customers as it expands affordable Joe V’s stores chron.com - October 3 at 6:01 PM
	Road rage incident leads to stabbing at H-E-B kens5.com - September 27 at 8:45 AM
	H-E-B announces new stores in Prosper, Melissa, Rockwall nbcdfw.com - September 25 at 7:28 PM
	How H-E-B rewrote the retail playbook therealdeal.com - September 10 at 2:56 PM
	H-E-B enters the film world with a five-part docuseries covering Texas parks and wildlife chron.com - August 28 at 6:36 PM
	Novel Drugs Targeting Toll-like Receptors for Antiviral Therapy medscape.com - July 23 at 12:58 PM
	Former H-E-B to become Tesla showroom, filings show statesman.com - July 20 at 12:34 AM
	Here's what happened to H-E-B's video rental store you forgot about mysanantonio.com - July 10 at 7:43 PM
	H-E-B opens doors to new Georgetown grocery store bizjournals.com - July 1 at 1:09 PM
	H-E-B should bring commercials back for No. 1 NBA Draft pick Wembanyama mysanantonio.com - June 29 at 8:53 PM
	Hemispherx's Ampligen Dealt FDA Blow thestreet.com - June 27 at 11:56 PM
	H-E-B celebrates Corpus Christi educators with the 2023 H-E-B Excellence in Education awards kristv.com - May 4 at 11:43 PM
	What is Mi Tienda? We took a tour of H-E-B's Mexican grocery store houstonchronicle.com - April 28 at 9:39 AM
	H-E-B opens first Fresh Bites convenience store in Central Texas mysanantonio.com - April 25 at 8:06 PM
	H-E-B heir back on Forbes billionaires list, Elon Musk falls from top mysanantonio.com - April 15 at 7:42 PM
	H-E-B crowned ultimate Texas brand in online competition beaumontenterprise.com - April 3 at 9:32 AM
	B&H Photo promo code for March 2023 pcgamer.com - March 30 at 2:50 PM
	YS Biopharma Down 38%; Reports Favorable Covid-19 Vaccine Results marketwatch.com - March 29 at 7:53 PM
	Here are five H-E-B products Texans love, as recommended by readers houstonchronicle.com - March 22 at 1:48 AM
	First Wave BioPharma Shares Rise 9% After Dosing First Patient With Adrulipase marketwatch.com - March 11 at 11:52 PM
	H-E-B is hiring hundreds of workers for its newest North Texas grocery store star-telegram.com - February 26 at 3:11 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

iShares Core Growth Allocation ETF

NYSEARCA:AOR

iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile. The Fund is designed for investors seeking moderate capital appreciation and opportunity for current income and capital preservation. The Fund's investment advisor is BlackRock Fund Advisors.

Eaton Vance Municipal Income 2028 Term Trust

NYSE:ETX

Eaton Vance Municipal Income 2028 Term Trust is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. It invests in the fixed income markets. The fund invest in stocks of companies operating across the diversified sectors. It was previously known as Eaton Vance Municipal Income Term Trust. Eaton Vance Municipal Income 2028 Term Trust was formed on March 28, 2013 and is domiciled in the United States.

Hemispherx BioPharma

NYSEAMERICAN:HEB

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of CFS, Hepatitis B, HIV, and cancer patients with renal cell carcinoma and malignant melanoma. The company was founded in 1990 and is headquartered in Orlando, Florida.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial